OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR
Delisted
OSIR was delisted on the 16th of April, 2019.
57 hedge funds and large institutions have $130M invested in Osiris Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 19 increasing their positions, 7 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
100% less call options, than puts
Call options by funds: $2K | Put options by funds: $963K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
57
Holding in Top 10
–
Calls
$2K
Puts
$963K
Top Buyers
| 1 | +$23.4M | |
| 2 | +$6.54M | |
| 3 | +$5.78M | |
| 4 |
Goldman Sachs
New York
|
+$4.94M |
| 5 |
WIC
Water Island Capital
New York
|
+$4.89M |
Top Sellers
| 1 | -$5.18M | |
| 2 | -$1.76M | |
| 3 | -$1.19M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$927K |
| 5 |
CG
Caprock Group
Boise,
Idaho
|
-$473K |